Arko Corp
6 nominees · 3 ballot items.
Election of six directors; advisory vote to approve named executive officer compensation; ratification of Grant Thornton as independent registered public accounting firm.
Follow how the vote landed and what changed on Arko Corp’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot3
- 1
Election of Directors
ManagementBoard: FORElect six directors to serve until the 2027 annual meeting or until their successors are elected and qualified.
- 2
Non-Binding Advisory Resolution Regarding the Compensation of our Named Executive Officers
ManagementBoard: FORNon-binding advisory vote to approve named executive officer compensation as disclosed in the proxy statement (say-on-pay).
More detail
This is a management-sponsored, advisory 'say-on-pay' proposal asking shareholders to approve, on a non-binding basis, the compensation disclosed for ARKO’s named executive officers in the proxy statement, including the CD&A, compensation tables and narrative. Management seeks this approval to validate its compensation philosophy (alignment to stakeholders, performance focus, competitiveness, simplicity and transparency) and to provide feedback for the Compensation Committee when making future pay decisions. The CD&A explains that the NEO compensation program emphasizes performance-based incentives (primarily EBITDA-linked PSUs and annual cash bonuses) and a mix of time-based RSUs to promote retention; CEO pay includes additional stock-price-based PSUs. The Board’s recommendation to vote FOR reflects its view that the program aligns pay with long-term value creation and retention needs, and that the 2025 metrics (EBITDA performance and some stock-price goals for CEO awards) are appropriate. Supporting context includes the Company’s 2025 achievement of approximately 100% of Annual Budgeted EBITDA, the Compensation Committee’s use of an independent consultant (Mercer), and prior shareholder feedback (approximately 74% support in 2025). The proposal is non-binding; even if approved, the Board retains discretion over compensation policies and awards. The principal governance issue is whether the pay program’s targets, metrics (EBITDA emphasis), and mix of cash and equity adequately align management incentives with shareholder interests given ARKO’s operational profile and related-party arrangements (e.g., ongoing commercial relationships with APC). Potential shareholder concerns include reliance on EBITDA (which management says excludes certain non-cash and non-recurring items), the CEO’s significant equity opportunity and stock-price-linked PSUs, and change-in-control and severance provisions that can yield substantial payouts. Analysts should weigh pay-for-performance metrics, historical payouts, and the company’s continuing operational integration with APC when evaluating the merits of the say-on-pay vote.
- 3
Ratification of Independent Registered Public Accounting Firm
ManagementBoard: FORRatify the appointment of Grant Thornton LLP as ARKO’s independent registered public accounting firm for the 2026 fiscal year.
Nominees on the ballot6
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 20.6% | 23,139,671 | $129M |
| 2 | Invesco Ltd. | 3.1% | 3,456,529 | $19M |
| 3 | DIMENSIONAL FUND ADVISORS LP | 2.4% | 2,734,451 | $15M |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 2.4% | 2,703,535 | $15M |
| 5 | BlackRock, Inc. | 2.3% | 2,607,850 | $14M |
| 6 | ARES MANAGEMENT LLC | 1.9% | 2,110,000 | $12M |
| 7 | BlackRock, Inc. | 1.8% | 2,017,503 | $11M |
| 8 | Phoenix Financial Ltd. | 1.7% | 1,941,817 | $11M |
| 9 | STATE STREET CORP | 1.6% | 1,801,757 | $10M |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 1.4% | 1,617,353 | $9M |
Other Consumer Cyclical sector meetings6
Upcoming shareholder meetings at Arko Corp’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Arko Corp 2026 annual meeting?
- Arko Corp (ARKO) holds its 2026 annual shareholder meeting on Thursday, June 4, 2026.
- What is the record date for the Arko Corp 2026 meeting?
- The record date for the Arko Corp 2026 meeting is Friday, April 10, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Arko Corp's 2026 meeting?
- The board is presenting 6 director nominees at the Arko Corp 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Arko Corp 2026 meeting?
- Shareholders will vote on 3 proposals at the Arko Corp 2026 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.